Neuromodulation is an emerging field that explores the use of electrical, chemical, and mechanical interventions to heal neurological deficits. Such neurostimulation has already shown great promise with disorders and diseases such as chronic pain, epilepsy, and Parkinson's disease. This is the first concise reference covering all of the basic principles of neuromodulation in a single affordable volume for neuro-residents, fellows, and basic clinical practitioners, edited by two prominent clinical experts in the field.
This volume emphasizes essential observations from all of the important clinical phases involved in any neuromodulation: targeting, intraoperative assessment, programming, complications, and complication avoidance. There are commonalities to all neuromodulation procedures that must be brought to the forefront to form a cohesive presentation of neuromodulation, and such emphasis will give readers a more solid grounding in the fundamentals needed to embrace this field as a cohesive clinical entity.
- Chapters offer point-counterpoint commentary for varied perspectives
- Appendix distills current guidelines in easy, accessible format
- Chapters follow story of patient care, effectively emphasizing general principles with supporting examples
- Offers outstanding scholarship, with over 20% of chapters involving international contributors
Inhaltsverzeichnis
1;Cover;2 2;Front matter;2 3;Essential Neuromodulation;2 4;Copyright;5 5;Contents;6 6;Contributors;10 7;Introduction;12 8;Part I - The Neuromodulation Approach;14 8.1;Chapter 1 - The Neuromodulation Approach;16 8.1.1;Introduction;16 8.1.2;History;17 8.1.3;Applications;21 8.1.4;Ethics;22 8.1.5;Cost;24 8.1.6;References;27 9;Part II - Regions of Application;30 9.1;Chapter 2 - Cerebral Surface;32 9.1.1;History;33 9.1.2;Anatomical constraints on targeting;34 9.1.3;Can cortical stimulation be optimized through modeling?;37 9.1.4;MI as a paradigm of cortical stimulation;42 9.1.5;Mechanism of action and parameters considerations;44 9.1.6;Comparing techniques of cortical stimulation;49 9.1.7;References;52 9.2;Chapter 3 - Cerebral Deep;60 9.2.1;Introduction;60 9.2.2;The thalamus;60 9.2.3;Globus pallidus pars internus (GPi);66 9.2.4;Subthalamic nucleus (STN);69 9.2.5;PedunculoponTine nucleus (PPN);70 9.2.6;Deep cerebral targets for psychiatric illness;71 9.2.7;Hypothalamus;73 9.2.8;Conclusion;74 9.2.9;References;75 9.2.10;Commentary on Cerebral Deep;82 9.2.11;References;84 9.3;Chapter 4 - Spinal Extradural;86 9.3.1;Introduction;86 9.3.2;Epidural spinal cord stimulation: the procedure;88 9.3.3;Epidural stimulation to target specific disease states;92 9.3.4;Contraindications to SCS;97 9.3.5;Programming the epidural leads;99 9.3.6;Conclusion;101 9.3.7;References;101 9.3.8;Commentary on Spinal Extradural;105 9.3.9;Mechanisms;105 9.3.10;Practice structure contribution;106 9.3.11;References;107 9.4;Chapter 5 - Peripheral Nerve;108 9.4.1;Introduction;108 9.4.2;General principles of PNS;108 9.4.3;Specific PNS applications;111 9.4.4;Vagal nerve stimulation;113 9.4.5;Conclusion;114 9.4.6;References;114 9.4.7;Commentary on Peripheral Nerve;118 10;Part III - The Neuromodulation Therapy Interface;120 10.1;Chapter 6 - The Electrode Materials and Configurations;122 10.1.1;Physical basis of the electrode/electrolyte interface;122 10.1.2;Charge injection across the electrodeelectrolyte interfa
ce during electrical stimulation;127 10.1.3;Charge injection for extracellular stimulation of excitable tissue;133 10.1.4;Mechanisms of damage;135 10.1.5;Design compromises for efficacious and safe electrical stimulation;138 10.1.6;Materials used as electrodes for charge injection and reversible charge storage capacity;142 10.1.7;Size and shape considerations;150 10.1.8;References;152 10.1.9;Commentary on The Electrode Materials and Configurations;160 10.1.10;Delivery of electrical energy;160 10.1.11;Optimizing neural atitivation;162 10.1.12;Injury produced by electrical stimulatiation;163 10.2;Chapter 7 - The Electrode Principles of the Neural Interface: Axons and Cell Bodies;166 10.2.1;Introduction;166 10.2.2;Electrodebrain interface;166 10.2.3;Electric field;167 10.2.4;Stimulated neural elements;169 10.2.5;Cable equation and activating function;169 10.2.6;Direct neural activation;170 10.2.7;Indirect synaptic modulation;171 10.2.8;Stimulation-induced network activity;172 10.2.9;References;173 10.2.10;Considerations for Quantitative Modeling of Excitation and Modulation of CNS neurons;175 10.2.11;Introduction;175 10.2.12;Part one: generation of potentials in tissue;176 10.2.13;Part two: effects of extracellular potential on neurons;177 10.2.14;Part three: network effects of CNS stimulation;179 10.2.15;References;180 10.3;Chapter 8 - The Electrode Principles of the Neural Interface: Circuits;182 10.3.1;Evidence in support of a DBS systems effect hypothesis;183 10.3.2;Evidence related to DBS systems versus local effects hypotheses;188 10.3.3;Regarding evidence for the DBS local effect hypothesis;190 10.3.4;Evidence for the DBS systems effect hypothesis;190 10.3.5;Implications of DBS for the physiology and pathophysiology of the BGTHCTX system;198 10.3.6;Intellectual antecedents to the DBS local effect;199 10.3.7;Implications of the DBS systems effect hypothesis onfuture surgical therapies;200 10.3.8;Final note;200 10.3.9;References;201 10.3.10;Commentary on The Elect
rode - Principles of the Neural Interface: Circuits ;204 10.4;Chapter 9 Device Materials, Handling, and Upgradability;206 10.4.1;Introduction;206 10.4.2;Neurostimulator form factor and materials;206 10.4.3;Lead system configuration and materials;211 10.4.4;Safety considerations;215 10.4.5;Conclusions;219 10.4.6;References;219 10.4.7;Commentary on Device Materials Handling, and Upgradability;222 10.4.8;References;223 10.5;Chapter 10 - Electronics;226 10.5.1;The history of SCS devices;226 10.5.2;The first implanted dorsal column stimulators;227 10.5.3;Electronics for spinal cord stimulation;231 10.5.4;Future;251 10.5.5;References;253 10.5.6;Commentary on Electronics;257 10.5.7;Basic definitions in pulse delivery;257 10.5.8;Current, charge density and dissipated energy in the example of spatial targeting of axon fibers;258 10.5.9;Spatial selectivity engineering by multielectrode grids;258 10.5.10;Temporal selectivity engineering based on interleaving;259 10.5.11;Constant current and voltage stimulation;260 10.5.12;Engineering aspects of the electronic circuits;262 10.5.13;Concluding remarks;264 10.5.14;References;264 10.6;Chapter 11 - Power;266 10.6.1;Overview;266 10.6.2;Power requirements;266 10.6.3;System power requirements;268 10.6.4;Patient compliance and cost considerations;272 10.6.5;Power source options;272 10.6.6;References;277 10.6.7;Commentary on The Electrode Power;279 11;Part IV - Placing Neuromodulation in the Human Body;282 11.1;Chapter 12 - Surgical Techniques;284 11.1.1;Introduction;284 11.1.2;Emphasizing the physiological target;284 11.1.3;Being attuned to nuances (tissue, physiology, and the patient);286 11.1.4;Assuring that intraoperative resources are adequate for decision making;291 11.1.5;Conclusions;292 11.1.6;References;293 11.1.7;Commentary on Surgical Techniques;294 11.1.8;Reference;294 11.2;Chapter 13 - Trials and Their Applicability;296 11.2.1;Introduction;296 11.2.2;Intrathecal infusion trials;296 11.2.3;Needle placement for intrathecal pum
p placement;299 11.2.4;Spinal cord stimulation trials;302 11.2.5;Selected reading;307 11.2.6;Commentary on Trials and Their Applicability;308 11.2.7;Neuroaxial opioids;308 11.2.8;Neurostimulation;309 11.2.9;References;311 11.3;Chapter 14 Limiting Morbidity;314 11.3.1;Infection;315 11.3.2;Hemorrhage;317 11.3.3;Injury of nervous tissue;319 11.3.4;Cerebrospinal fluid leak;322 11.3.5;Placing the device into the wrong compartment;324 11.3.6;Hardware migration;325 11.3.7;Hardware erosion;327 11.3.8;Hardware malfunction/fracture/disconnection;328 11.3.9;Granuloma formation;329 11.3.10;Other issues;331 11.3.11;References;331 11.3.12;Commentaryon LimitingMorbidity;334 11.3.13;Infection/erosion;334 11.3.14;CSF leak following intrathecal catheter placement;335 11.3.15;Complicatiations following SCS paddle lead implantatiantation;336 11.3.16;Lead fracture;336 12;Part V - Troubleshooting and Repair;338 12.1;Chapter 15 Intraoperative Evaluation;340 12.1.1;Introduction;340 12.1.2;Principles of assessment;341 12.1.3;Non-invasive testing;347 12.1.4;Intraoperative testing;353 12.1.5;Testing methodology;354 12.1.6;Examples;355 12.1.7;Conclusion;357 12.1.8;References;358 13;Part VI - Postoperative Management;362 13.1;Chapter 16 - Programming DBS Programming;364 13.1.1;Introduction;364 13.1.2;Overview;364 13.1.3;Process;366 13.1.4;Initial programming session;369 13.1.5;Follow up;374 13.1.6;Maintenance;379 13.1.7;Alternative programming methods;380 13.1.8;Patient control;381 13.1.9;Conclusion;382 13.1.10;References;382 13.1.11;Commentary on Programming DBS Programming;385 13.2;Chapter 17 - Programming SCS;388 13.2.1;Introduction;388 13.2.2;Anatomical considerations in spinal cord stimulation;388 13.2.3;Programmable aspects of stimulation;392 13.2.4;Intraoperative programming;398 13.2.5;Postoperative programming;400 13.2.6;Conclusions;405 13.2.7;References;406 13.2.8;Commentary on Programming SCS;408 13.2.9;References;409 13.3;Chapter 18 Safety Concerns and Limitations;410 13.3.1;Patient
activity and environmental concerns;410 13.3.2;Medical imaging;415 13.3.3;Medical and surgical interventions;418 13.3.4;Conclusions;421 13.3.5;References;421 13.3.6;Commentaryon Safety Concerns and Limitations;424 14;Part VII - The End User;426 14.1;Chapter 19 - Expectations and Outcomes;428 14.1.1;Expectations and outcomes;428 14.1.2;Deep brain stimulation for movement disorders;428 14.1.3;Spinal cord stimulation for pain;433 14.1.4;Motor cortex stimulation for neuropathic pain;434 14.1.5;Vagal nerve stimulation for epilepsy;435 14.1.6;Expectations of the patient;436 14.1.7;Considerations from a patients perspective: psychology of pill burden;437 14.1.8;Conclusions;438 14.1.9;References;438 14.1.10;Commentaryon Expectations and Outcomes;442 14.2;Chapter 20 - Neuromodulation Perspectives;448 14.2.1;Introduction;448 14.2.2;Should we say DBS-HF or simply DBS?;449 14.2.3;Targeting;449 14.2.4;Anesthesia;452 14.2.5;How to choose best practice?;453 14.2.6;Suicide and cognitive effects;456 14.2.7;Mechanism of action;457 14.2.8;Should we go back to lesioning and unilateral implantation?;458 14.2.9;Costs;460 14.2.10;Evidence-based medicine (EBM) and clinical trials;460 14.2.11;Alternative methods and conclusion;463 14.2.12;Commentaryon Neuromodulation Perspectives;464 14.2.13;History as the future;464 14.2.14;The DBS frequency story;467 14.2.15;The surgical procedure, including anesthesia, from the neurophysiologist/neurologist perspective;470 14.2.16;The art, and hopefully, the science of choosing the best practice ;471 14.2.17;Reflecting prospectively;473 14.2.18;References;475 15;Appendix;478 16;Index;496